Terms: = Thyroid cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Treatment
4 results:
1. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/idh2 axis.
Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
Umphlett M; Shea S; Tome-Garcia J; Zhang Y; Hormigo A; Fowkes M; Tsankova NM; Yong RL
BMC Cancer; 2020 Jan; 20(1):47. PubMed ID: 31959133
[TBL] [Abstract] [Full Text] [Related]
4. Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study idh1R132 mutation effects in human glioblastoma.
Atai NA; Renkema-Mills NA; Bosman J; Schmidt N; Rijkeboer D; Tigchelaar W; Bosch KS; Troost D; Jonker A; Bleeker FE; Miletic H; Bjerkvig R; De Witt Hamer PC; Van Noorden CJ
J Histochem Cytochem; 2011 May; 59(5):489-503. PubMed ID: 21527585
[TBL] [Abstract] [Full Text] [Related]
